CasLoc logo
All Cases PTAB Litigations UPC Oppositions

JANSSEN PHARMACEUTIC v. MYLAN PHARMACEUTICAL

2:03-cv-06220

Overview

Case Number 2:03-cv-06220
Filing Date 2003-12-30
Status Terminated
Termination Date 2007-12-07
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

MYLAN PHARMACEUTICALS INC. Operating Company

Represented By

2 Attorneys Listed

JEFFREY S. SOOS

SAIBER LLC

Tel: +1 (973) 622-3333
Fax: +1 (973) 622-3349

SAIBER LLC, ONE GATEWAY CENTER

ARNOLD B. CALMANN

SAIBER LLC

Tel: +1 (973) 622-3333
Fax: +1 (973) 622-3349

SAIBER LLC, ONE GATEWAY CENTER

Plaintiff

JANSSEN PHARMACEUTICA N.V. NPE (Individual / Inventor)

Represented By

5 Attorneys Listed

DOUGLAS SCOTT EAKELEY

LOWENSTEIN SANDLER PC

Tel: +1 (973) 597-2500

65 LIVINGSTON AVENUE, ROSELAND, NJ 07068-1791

KAYLYNN SUN-LEE YOON

KIRKPATRICK & LOCKHART PRESTON GATES ELLIS

Tel: +1 (973) 848-4000

KIRKPATRICK & LOCKHART PRESTON GATES ELLIS, ONE NEWARK CENTER

RITA MARIE JENNINGS

LOWENSTEIN SANDLER

Tel: +1 (973) 597-2516

LOWENSTEIN SANDLER, 65 LIVINGSTON AVENUE

MATTHEW JONATHAN ATLAS

LOWENSTEIN SANDLER, PC

Tel: +1 (973) 597-2384

65 LIVINGSTON AVENUE, ROSELAND, NJ 07068

JOHN RICHARD MIDDLETON , JR.

BUCKALEW FRIZZELL & CREVINA LLP

Tel: +1 (609) 951-2219

116 VILLAGE BOULEVARD, SUITE 200

JANSSEN PHARMACEUTICA PRODUCTS, L.P. Operating Company

Represented By

5 Attorneys Listed

DOUGLAS SCOTT EAKELEY

LOWENSTEIN SANDLER PC

Tel: +1 (973) 597-2500

65 LIVINGSTON AVENUE, ROSELAND, NJ 07068-1791

KAYLYNN SUN-LEE YOON

KIRKPATRICK & LOCKHART PRESTON GATES ELLIS

Tel: +1 (973) 848-4000

KIRKPATRICK & LOCKHART PRESTON GATES ELLIS, ONE NEWARK CENTER

RITA MARIE JENNINGS

LOWENSTEIN SANDLER

Tel: +1 (973) 597-2516

LOWENSTEIN SANDLER, 65 LIVINGSTON AVENUE

MATTHEW JONATHAN ATLAS

LOWENSTEIN SANDLER, PC

Tel: +1 (973) 597-2384

65 LIVINGSTON AVENUE, ROSELAND, NJ 07068

JOHN RICHARD MIDDLETON , JR.

BUCKALEW FRIZZELL & CREVINA LLP

Tel: +1 (609) 951-2219

116 VILLAGE BOULEVARD, SUITE 200

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2006-03-07
2:06-cv-01020

JANSSEN PHARMACEUTICAL, N.V. v. APOTEX, INC.

Asserted Patent
Status: NJD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US4804663
3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
Filed: 1986-02-05
Issued: 1989-02-14
Expired (Term Ended) +692d PTA
Expires: 2007-12-29

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+692 days) / Cellect Scrutiny β€” Over 692 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

20

Dispositive

18

Granted

0

Denied

0

Pending / Review

20

Motions by Category

Motion to Strike / Sanctions 1 Procedural / Extension Motion 1 Motion for Preliminary Injunction / TRO 18

Key Dispositive Motions & Rulings

Motion for Preliminary Injunction / TRO Pending / Under Review
REPLY to Response to Motion re 55 MOTION for Preliminary Injunction filed by JANSSEN PHARMACEUTICA N.V., JANSSEN PHARMACEUTICA PRODUCTS, L.P.. (Attachments: # 1...
Entry #78 • 2006-06-15 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
MOTION to Seal Portions of Janssen's Reply Brief in Support of Janssen's Motion for a Preliminary Injunction by JANSSEN PHARMACEUTICA N.V., JANSSEN PHARMACEUTIC...
Entry #79 • 2006-06-15 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
RESPONSE in Opposition re 55 MOTION for Preliminary Injunction Rebuttal Report of John L. Neumeyer, Ph.D (Tab A) filed by MYLAN PHARMACEUTICALS INC.. (Attachmen...
Entry #72 • 2006-06-05 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
RESPONSE in Opposition re 55 MOTION for Preliminary Injunction Rebuttal Report of Manfred E. Wolff (Tab A) filed by MYLAN PHARMACEUTICALS INC.. (Attachments: # ...
Entry #73 • 2006-06-05 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
RESPONSE in Opposition re 55 MOTION for Preliminary Injunction Supplemental Report of Manfred E. Wolff (Tab A) filed by MYLAN PHARMACEUTICALS INC.. (Attachments...
Entry #74 • 2006-06-05 Document →
Motion for Preliminary Injunction / TRO Pending / Under Review
MOTION to Seal Materials Filed in Connection with Defendants' Brief in Opposition to Plaintiffs' Motion for Entry of a Preliminary Injunction by MYLAN PHARMACEU...
Entry #76 • 2006-06-05 Document →

Docket Entries

(167 total)
Motion to Strike / Sanctions Pending / Under Review

COMPLAINT filed w/Rule 11.2 certf and exhibits FILING FEE $ 150.00 RECEIPT # 320705 (MD) Additional attachment(s) added on 6/19/2006 (tll, ). (Entered: 12/31/2003)

Entry #1 • 2003-12-30
1

STATEMENT (Corporate Disclosure) pursuant to Rule 7.1(a) by JANSSEN PHARMACEUTIC, JANSSEN PHARMACEUTIC (MD) Additional attachment(s) added on 6/19/2006 (tll, ). (Entered: 12/31/2003)

Entry #2 • 2003-12-30
1

NOTICE of Allocation and Assignment filed. ( Newark - Judge Bissell - Magistrate Judge Haneke) (NM) (MD) Additional attachment(s) added on 6/19/2006 (tll, ). (Entered: 12/31/2003)

Entry #3 • 2003-12-31
1
Procedural / Extension Motion Pending / Under Review

Application and Clerk's Order to extend time to answer as to MYLAN PHARMACEUTICALS INC. Attorney ARNOLD B. CALMANN for MYLAN PHARMACEUTICALS INC. added. answer due 2/4/04. (DD, ) (Entered: 02/04/2004)

Entry #5 • 2004-01-20
1
Pleading / Complaint

SUMMONS Returned Executed by JANSSEN PHARMACEUTICA N.V., JANSSEN PHARMACEUTICA PRODUCTS, L.P.. MYLAN PHARMACEUTICALS INC. served on 1/8/2004, answer due 1/28/2004. (jr) (Entered: 02/03/2004)

Entry #4 • 2004-01-23
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc